Manufacture/distributor BR-PH
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2D020D0009
- Awardee
-
Fresenius Kabi, LLC UEI C2TRNWNQKMD6
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Task orders
- 3,038 $13,225,894 obligated
Award facts
- Opportunity
-
- SPE2D015R0002 Solicitation number
- Combined order value
- $13,225,894 Current and potential, with all options
- Last date to order 62% complete
- IDV ceiling 34% used
- $39,209,281.96
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
The Medical Supply Chain awarded an indefinite-delivery contract to Fresenius Kabi, LLC on July 30, 2020, with a ceiling value of $39.2 million, ultimate completion date of July 29, 2030, and single-award status. No set-aside was used.
Place of performance is Lake Zurich, Illinois. The IDIQ procures injectable pharmaceutical products including atropine, midazolam, ketorolac, furosemide, diphenhydramine, xylocaine, dexamethasone, imipenem-cilastatin, rocuronium, and ustekinumab to support federal medical supply chains. The contract operates under NAICS 325412 (medicinal and botanical manufacturing).
Recent delivery order activity, issued between late June and late July 2026, reflects high-volume, low-dollar transactional work across a broad range of injectable formulations. Orders are priced firm fixed price with completion dates spanning one to thirteen months from issuance. Representative recent orders include a $1.3 million delivery order for injectable pharmaceutical products with ultimate completion August 30, 2027; multiple ketorolac orders in the hundreds of dollars; and individual vial orders for atropine, xylocaine, diphenhydramine, vancomycin, gentamicin, calcium gluconate, and dexamethasone ranging from twenty-three to six hundred thirty-nine dollars. All delivery orders draw from the same funding federal agency and place of performance.
Task orders
Show 40 more
Latest 50 of 3,038 listed here. See the rest on GovTribe.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Show all 14
Quick answers
Who was awarded contract SPE2D020D0009?
SPE2D020D0009 was awarded to Fresenius Kabi, LLC by Medical Supply Chain (Troop Support) on July 30, 2020.
How much is contract SPE2D020D0009 worth?
Orders under SPE2D020D0009 have obligated $13,225,894. SPE2D020D0009's own ceiling is $39,209,282.
How many orders have been placed under contract SPE2D020D0009?
3,038 orders have been placed under SPE2D020D0009, the latest on July 27, 2026.
Who can order from contract SPE2D020D0009?
SPE2D020D0009 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2D020D0009 competed?
The extent of competition for SPE2D020D0009 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV